RenovoRx Inc. (RNXT) stock prices surged by 19.14% some time after market trading commenced on September 7th 2021. This brought the price per share up to USD$9.43 early on in the trading day. RenovoCath Delivery System Approval September 7th 2021 saw RNXT stock announce having received a new 510(k) clearance for its proprietary RenovoCath Delivery …
Eyegate Pharmaceuticals Inc. (EYEG) stock prices surged 0.27% to USD$3.75 shortly after market trading commenced on September 7th 2021. EYEG Stock’s R&D Expenses Research and development expenses came out to USD$1.44 million for the second quarter of fiscal 2021. This is comparable to the USD$0.631 million reported for the prior year quarter. the year over …
Immunome Inc. (IMNM) stock prices were up by 5.96% shortly after market trading commenced on September 7th 2021. This brought the price per share up to USD$16.00 early on in the trading day. IMM-BCP-01 Effective against Covid-19 Strains The biopharmaceutical company announced on September 7th 2021 that its three-antibody cocktail (IMM-BCP-01) exhibited potent neutralizing activity …
Recon Technology Ltd. (RCON) stock prices were up by 0.050% shortly after market trading commenced on September 7th, 2021. This brought the price per share up to USD$3.21 early on in the trading day. RCON Stock’s Contract with PetroChina September 7th, 2021 saw RCON stock announce signing a service contract with PetroChina. This agreement is …
Adaptimmune Therapeutics plc (ADAP) stock soared today following the announcement of Strategic Collaboration with Genentech. ADAP stock price saw a surge of 15.90% to reach $5.73 a share at the time of this writing. The stock in the previous trade closed with a $4.94 per share price with no loss or gain. Let’s dig in …
Why is Adaptimmune Therapeutics plc (ADAP) stock soaring today? Read More »
111 Inc. (YI) stock prices closed the trading day on September 3rd, 2021 at USD$6.56, the same price it opened at. Subsequent current market fluctuations saw the stock surge by 5.95%, bringing it up to USD$6.95. YI Stock Invests in Growth The second quarter of fiscal 2021 saw YI stock continue investing in the development …
111 Inc. (YI) Stock Surges Following Announcement of Share Repurchase Program Read More »
Alset EHome International Inc. (AEI) stock rallied in the Pre-market today on September 7, 2021, despite no specific news. AEI stock price saw a push of 5.71% to reach $2.22 a share at the time of this writing. The stock was gloomy in the previous trade and went down by 6.67% at closing. Alset EHome …
Why Alset EHome International Inc. (AEI) stock rallied in Pre-Market? Read More »
PROG experienced an increase of 7.21% in the premarket. The last trading session closed at $0.06 with an increase of 5.71%. Participation in the Upcoming Investor Conferences by PROG PROG has announced on 3rd September 2021 that it would take part in two forthcoming virtual investor conferences: On September 13, 2021, at 7 a.m. ET …
Progenity, Inc. (PROG) stock price rose in premarket, why? Read More »
ENVB shares are rising in the premarket on 7th September 2021. ENVB stock saw a gain of 0.76% to reach $2.65. However, the last trading session closed at $2.63 with an increase of 19%. What’s going on? Enveric Biosciences, Inc is a pharmaceutical company that focuses on the research and development of cannabis medications to …
Enveric Biosciences, Inc. (ENVB) stock price rose in premarket, why? Read More »
Mechel PAO (MTL), a company engaged in mining, power, and steel businesses, has seen a tremendous increase of 37.19% in the premarket trading session. As a result, MTL stock is changing hands at $4.39 at the time of writing. On Monday, MTL stock closed the day at $3.20, a decrease of 1.54%. Appointment of CFO …
Mechel PAO (MTL) Stock on a Rapid Surge in Pre-Market Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.